Table 1.
Descriptive characteristics of arboviral cases reported by data source in Cali, Medellin, and Villavicencio (Colombia), 2014–2017.
Fig 1.
Agreement between health care facility’s diagnosis and SIVIGILA’s notified diagnosis of arboviral diseases in Colombia (2014–2017).
Fig 1A: Healthcare facility’s diagnosis and SIVIGILA’s reporting in Cali. Fig 1B: Healthcare facility’s diagnosis and SIVIGILA’s reporting diagnosis in Medellin. Fig 1C: Healthcare facility’s diagnosis and SIVIGILA’s reporting diagnosis in Villavicencio. Non-Specified Vector-Borne Diseases (Non-specified VBDs).
Table 2.
Agreement between health care facility’s diagnosis and SIVIGILA’s notified diagnosis of arboviral diseases in Cali, Medellin, and Villavicencio (Colombia) 2014–2017.
Table 3.
Factors associated to reporting of arboviral diseases in Cali, Medellin, and Villavicencio, 2014–2017.
Fig 2.
Adjusted predicted probability and 95% CIs of reporting to SIVIGILA by clinical diagnosis and year of reporting in Cali, Medellin, and Villavicencio (Colombia) 2014–2017.
Non-specified vector-borne diseases (Non-specified VBDs).
Fig 3.
Simulation Extrapolation results: Measurement Error estimation of the reporting by disease, adjusted by age and year of reporting in Cali, Medellin, and Villavicencio (Colombia) 2014–2017.
The estimated rates on the log scale are presented on the Y axis and the degree/change of misclassification error (Lambda) on the X axis. The dotted line at error level zero in the X axis indicates the observed rates (i.e: uncorrected rates, Table 3) and the estimates at the error level -1, indicates the extrapolated (corrected) rates accounting for the misclassification error. Estimates from error level 0.5 to error level 2, indicate the change in the estimated rates of reporting by adding different levels of misclassification error. Top: results using the observed values of accuracy (sensitivity) for the diagnosis. Bottom: results assuming high accuracy (90% correctly identified) of the clinical diagnosis. Other VBD refers to non-specified vector-borne diseases.